Advertisement
  • Treating Cancer Based on Its Genetics, Not Its Location

    Medical oncologist and sarcoma specialist George D. Demetri explains the significance of the recent approval of the oral drug Vitrakvi based on tumor genetics.

    by Anna Azvolinsky

  • Reinforcements for Cancer Research

    Scientific meeting emphasizes the importance of patient advocates in helping researchers to reduce cancer health disparities.

    by Marci A. Landsmann

  • Guiding Care

    Medical oncologist Gabrielle Rocque explains the role of clinical practice guidelines in breast cancer care.

    by Anna Azvolinsky

  • Does Medicaid Expansion Have an Impact?

    Analysis suggests states that opted for Medicaid expansion had higher use of hormone therapy for breast cancer patients.

    by Marci A. Landsmann

  • Achieving Health Equality

    National Cancer Institute director Norman “Ned” Sharpless describes the challenge and opportunity of studying cancer disparities.

    by Marci A. Landsmann

  • An Uncommon Partnership

    Through the Angiosarcoma Project, researchers are partnering with patients to learn about a rare cancer.

    by Ashley P. Taylor

  • Vaccinating Against Cancer

    The human papillomavirus vaccine can significantly cut recipients' risk of several types of cancer. So why are vaccination rates relatively low in the U.S.?

    by Brad Jones

  • The Genetics of Metastatic Cancer

    The multiple tumors in patients with metastatic disease share key genetic traits, a sequencing study shows.

    by Anna Azvolinsky

  • Forward Look

    What’s Next? Fall 2018

    High-tech goggles to help surgeons remove tumors.

    by Brad Jones

  • New Tactics for Bladder Cancer

    After decades without treatment advances, options for patients with bladder cancer are now more numerous.

    by Kendall K. Morgan